00:00Sure, first we're excited because we're at a pretty significant moment in history for our company.
00:07We've expanded our innovation and our pipeline for a lot of new therapeutic areas
00:12and ones that have significant global demand and importance to patients,
00:17especially in diabetes and soon obesity.
00:20And so we're expanding our production capacity to meet the needs of patients worldwide.
00:26And Sesto Fiorentino has been a strategic hub for us to actually produce significant amounts in export
00:36across to many countries across the globe, which means a lot to patients worldwide.
00:41So one of the reasons we've expanded here is one, the site has been very successful in production.
00:47We have great access to talent here in Italy.
00:52And we've, as part of the $750 million commitment,
00:57it's both an expansion of our production capacity here in Sesto Fiorentino,
01:01but also the ability to partner with Italian companies as well,
01:06to partner in new therapeutic areas where we've seen advancements in our pipeline.
01:11Well, the future is bright for our facility here in Sesto Fiorentino.
01:16We'll expand a number of jobs here and expand in what we currently produce here,
01:22which is for diabetes and in the future for obesity.
01:25That's going to be one of the most critical components.
01:28We also have elements of immunology and oncology as well in Italy.
01:33So the future is very bright in Sesto.
01:36So the future is very bright in Sesto Fiorentino.
Commenti